Pedro Simões

5PUBLICATIONS
41CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 10, 2026
EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study.

|Feb 26, 2026
Assessing the Impact of Comprehensive Genomic Profiling on Therapeutic Selection for Advanced Solid Tumors in Portugal.

Nuno Tavares, Pedro Simões, Raquel Lopes-Brás

|Mar 13, 2025
Avelumab Maintenance Therapy in Advanced Urothelial Carcinoma: Implications of Timing and Treatment Sequencing.

Lisa Gonçalves, Helena Guedes, Ana Raquel Fortuna

|Oct 31, 2022
Neuroendocrine carcinoma of vagina with prolonged survival.

Luísa Leal-Costa, João Godinho, Pedro Simões

|May 25, 2022
Non-alpine primary thyroid angiosarcoma.

Nádia Mourinho Bala, Pedro Simões, José Maria Aragüés

Pageof 1

Frequent Collaborators

2 joint publications

Diogo Alpuim Costa

1 joint publications

Nádia Mourinho Bala

1 joint publications

José Maria Aragüés

1 joint publications

Ricardo Veiga